Caractérisation et validation des facteurs d'échange de RhoA comme nouvelles cibles thérapeutiques dans l'hypertension artérielle. – GEFS HTA
Project coordination
Gervaise LOIRAND (Organisme de recherche)
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
Partner
Help of the ANR 320,000 euros
Beginning and duration of the scientific project:
- 36 Months